The estimated Net Worth of Bio Ventures Ii Lp Quaker B... is at least $2.35 Milion dollars as of 8 November 2019. Bio B owns over 153,846 units of TELA Bio stock worth over $2,346,073 and over the last 5 years Bio sold TELA stock worth over $0.
Bio has made over 1 trades of the TELA Bio stock since 2019, according to the Form 4 filled with the SEC. Most recently Bio bought 153,846 units of TELA stock worth $1,999,998 on 8 November 2019.
The largest trade Bio's ever made was buying 153,846 units of TELA Bio stock on 8 November 2019 worth over $1,999,998. On average, Bio trades about 76,923 units every 0 days since 2019. As of 8 November 2019 Bio still owns at least 888,664 units of TELA Bio stock.
You can see the complete history of Bio B stock trades at the bottom of the page.
Bio's mailing address filed with the SEC is 150 MONUMENT ROAD,150 MONUMENT ROAD,, SUITE 207SUITE 207, BALA CYNWYDBALA CYNWYD, PAPA, 1900419004.
Over the last 5 years, insiders at TELA Bio have traded over $4,222,376 worth of TELA Bio stock and bought 4,343,227 units worth $46,898,981 . The most active insiders traders include Management Inc. Opaleye, Investments, Lpwong Roderic... a Advisors Llc Orbi Med Capit.... On average, TELA Bio executives and independent directors trade stock every 18 days with the average trade being worth of $139,070. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 28 June 2024, trading 428,300 units of TELA stock currently worth $2,021,576.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio executives and other stock owners filed with the SEC include: